Related Experiment Videos
Osteopenia: a bone disorder associated with diabetes mellitus
Valéria M G Duarte1, Ana M O Ramos, Luciana A Rezende
1Departamento de Análises Clínicas e Toxicológicas, Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, 59010-180 Natal, RN, Brazil.
Journal of Bone and Mineral Metabolism
|December 24, 2004
Summary
Experimental diabetes in rats leads to osteopenia, characterized by increased bone spacing and reduced bone volume. Bone turnover markers and decreased serum calcium indicate significant bone metabolism alterations over time.
Area of Science:
- Endocrinology
- Bone Metabolism
- Diabetology
Background:
- Osteopenia is linked to human diabetes mellitus, but its underlying mechanisms remain unclear.
- Understanding diabetic osteopenia is crucial for managing bone health in diabetic patients.
Purpose of the Study:
- To investigate the impact of experimental diabetes on bone histomorphometry, bone mineral density (BMD), and bone metabolism biomarkers in rats.
- To assess the temporal relationship between diabetes duration and the development of osteopenia.
Main Methods:
- Alloxan-induced diabetes in female Wistar rats, divided into control and diabetic groups.
- Evaluation of femoral histomorphometry, BMD using dual-energy X-ray absorptiometry (DXA), and serum biomarkers (ALP, TRAP, calcium, albumin).
Main Results:
- Diabetic rats exhibited increased femoral trabecular distance, reduced trabecular thickness, and decreased bone trabecular volume.
- Significant increases in serum alkaline phosphatase (ALP) and tartarate-resistant acid phosphatase (TRAP) were observed in diabetic rats.
- Decreased serum calcium and albumin levels were noted in diabetic rats, suggesting impaired bone turnover and metabolic disturbances.
Conclusions:
- The diabetic state is associated with significant alterations in bone turnover.
- These alterations contribute to the development of osteopenia, with severity correlating to the duration of diabetes.
- Experimental diabetes negatively impacts bone health, highlighting the need for monitoring bone metabolism in diabetic individuals.